Andrea Kerrigan MS U.S. FDA

Andrea Kerrigan is a Branch Chief in CVM’s Office of Generic Animal Drugs, Division of Manufacturing Technologies. Her expertise is in sterile drug manufacturing, generic drug development and policy, pre-approval drug inspections, and cGMP compliance. She has been with FDA/CVM since 2009, first as a chemistry, manufacturing, and controls (CMC) reviewer. Before joining the FDA, she worked as a medicinal chemist in drug research and development. She earned her Bachelor’s degree in Chemistry from Butler University and Masters degree in Organic Chemistry from the University of Pennsylvania.